This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Industry Outlook Highlights Bain Capital Specialty Finance, PennantPark Investment and Stellus Capital Investment
by Zacks Equity Research
Bain Capital Specialty Finance, PennantPark Investment and Stellus Capital Investment are part of the Zacks Industry Outlook article.
3 SBIC & Commercial Finance Stocks to Buy Despite Industry Challenges
by Swayta Shah
Relatively higher rates and muted economic growth will affect demand for personalized financing. Yet, Zacks SBIC & Commercial Finance industry players like BCSF, PNNT and SCM are worth considering.
HTGC's Q1 Earnings Lag Estimates, Total Investment Income Dips
by Zacks Equity Research
Hercules Capital's first-quarter 2025 earnings narrowly miss estimates due to a dip in total investment income amid a modest rise in expenses.
Bain Capital Specialty (BCSF) Loses -6.85% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Bain Capital Specialty (BCSF) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks Industry Outlook Highlights Kayne Anderson BDC and Bain Capital
by Zacks Equity Research
Kayne Anderson BDC and Bain Capital have been highlighted in this Industry Outlook article.
2 SBIC & Commercial Finance Stocks to Buy Amid Industry Challenges
by Swayta Shah
Weak asset quality is a near-term headwind for the Zacks SBIC & Commercial Finance industry. Yet, a rise in financing demand across sectors as rates come down will support companies like Kayne Anderson (KBDC) and Bain Capital (BCSF).
Oracle's (ORCL) Healthcare Expansion to Aid Long-Term Growth
by Zacks Equity Research
Oracle's (ORCL) portfolio of healthcare offerings expands with the latest Oracle Health Insurance Data Exchange Cloud Service, which is expected to aid long-term growth.
Oracle (ORCL) Launches AI Assistant for Healthcare Providers
by Zacks Equity Research
Oracle (ORCL) announces the general availability of its Clinical Digital Assistant, an AI-powered tool designed to improve patient care in ambulatory clinics across the United States.
Does Oracle's (ORCL) Healthcare Roster Suggest Bright Prospects?
by Zacks Equity Research
Oracle's (ORCL) portfolio of offerings and increased adoption in the healthcare sector are expected to aid top-line growth in the near term.
Are Finance Stocks Lagging Bain Capital Specialty Finance (BCSF) This Year?
by Zacks Equity Research
Here is how Bain Capital Specialty (BCSF) and AllianceBernstein (AB) have performed compared to their sector so far this year.